|
WWC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.789200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.060190E-02 |
| Normal-vs-Stage2 |
2.064400E-03 |
| Normal-vs-Stage3 |
4.91140000002943E-06 |
| Normal-vs-Stage4 |
3.84050000000746E-05 |
| Stage1-vs-Stage2 |
3.138000E-01 |
| Stage1-vs-Stage3 |
9.037900E-03 |
| Stage1-vs-Stage4 |
2.914000E-02 |
| Stage2-vs-Stage3 |
4.273000E-01 |
| Stage2-vs-Stage4 |
3.086000E-01 |
| Stage3-vs-Stage4 |
7.040800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.34710000000171E-05 |
| Normal-vs-AfricanAmerican |
6.887400E-01 |
| Normal-vs-Asian |
3.499700E-02 |
| Caucasian-vs-AfricanAmerican |
8.123600E-02 |
| Caucasian-vs-Asian |
2.043200E-01 |
| AfricanAmerican-vs-Asian |
2.913000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87321999999268E-05 |
| Normal-vs-Female |
1.881000E-03 |
| Male-vs-Female |
2.041000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.472200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.831100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.86135999999948E-05 |
| Normal-vs-Age(81-100Yrs) |
3.389800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.221240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.620200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.858000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.467400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.343600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.87910000021874E-07 |
| Classical-VS-Follicular |
3.490000E-01 |
| Classical-VS-Other |
3.820400E-01 |
| Classical-VS-Normal |
6.760200E-03 |
| Tall-VS-Follicular |
9.603300E-04 |
| Tall-VS-Other |
2.039000E-01 |
| Tall-VS-Normal |
5.51760004352531E-09 |
| Follicular-VS-Other |
5.809600E-01 |
| Follicular-VS-Normal |
2.682400E-03 |
| Other-VS-Normal |
3.655600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.045500E-04 |
| Normal-vs-N1 |
1.081550E-03 |
| N0-vs-N1 |
8.603200E-01 |
|
|
